Cytotoxicity of human prostate cancer cell lines in vitro and induction of apoptosis using 213Bi-Herceptin α-conjugate
- 18 March 2004
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 205 (2) , 161-171
- https://doi.org/10.1016/j.canlet.2003.10.035
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomasBritish Journal of Cancer, 2002
- Herceptest: Her2 expression and gene amplification in non-small cell lung cancerInternational Journal of Cancer, 2001
- Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assaysJournal of Clinical Pathology, 2000
- Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis ofHER-2/neu gene amplification in breast cancer fine-needle samplesCancer, 1999
- Genetic evolutionary staging of early non–small cell lung cancer: The p53 → Her-2/neu → ras sequenceThe Journal of Thoracic and Cardiovascular Surgery, 1999
- HER-2/neuOncogene Amplification by Fluorescence In Situ Hybridization in Epithelial Tumors of the OvaryAmerican Journal of Clinical Pathology, 1999
- Prognostic significance of HER-2/neu gene amplification status by fluorescence in Situ hybridization of prostate carcinomaCancer, 1997
- Proto-Oncogenes and Tumor Suppressor Genes in Human Urological MalignanciesJournal of Urology, 1994
- p53, c-erbB-2 and the Epidermal Growth Factor Receptor in the Benign and Malignant ProstateJournal of Urology, 1992
- Expression of c‐erb B‐2/neu proto‐oncogene in human prostatic cancer tissues and cell linesMolecular Carcinogenesis, 1992